share_log

Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors

Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors

輝瑞 | 8-K:Cyrus Taraporevala當選爲輝瑞董事會成員
美股sec公告 ·  07/01 08:08
Moomoo AI 已提取核心訊息
On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.
On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.
輝瑞公司於2024年6月27日宣佈任命Cyrus Taraporevala爲其董事會成員,立即生效。擁有豐富的投資管理和金融市場背景的Taraporevala曾擔任State Street Global Advisors總裁和首席執行官,並在其他金融機構擔任領導職務。他的董事會選舉還包括被任命爲審計委員會和薪酬委員會成員。輝瑞公司董事長兼首席執行官Albert Bourla對Taraporevala的豐富經驗表示信懇智能,並認爲他將成爲輝瑞和其股東的資產。公司強調Taraporevala的全球運營經驗和領導力是有助於實現輝瑞改變患者生命的突破性發展任務的關鍵因素之一。正式公告發表於2024年7月1日的新聞發佈會上。
輝瑞公司於2024年6月27日宣佈任命Cyrus Taraporevala爲其董事會成員,立即生效。擁有豐富的投資管理和金融市場背景的Taraporevala曾擔任State Street Global Advisors總裁和首席執行官,並在其他金融機構擔任領導職務。他的董事會選舉還包括被任命爲審計委員會和薪酬委員會成員。輝瑞公司董事長兼首席執行官Albert Bourla對Taraporevala的豐富經驗表示信懇智能,並認爲他將成爲輝瑞和其股東的資產。公司強調Taraporevala的全球運營經驗和領導力是有助於實現輝瑞改變患者生命的突破性發展任務的關鍵因素之一。正式公告發表於2024年7月1日的新聞發佈會上。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息